Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 77 | 179 | 2,055 | 164 | 4 |
| Cost of Goods | 269 | 186 | 188 | 272 | 272 |
| Gross Profit | -192 | -7 | 1,867 | -108 | -268 |
| Operating Expenses | 3,584 | 3,357 | 3,703 | 4,138 | 4,546 |
| Operating Income | -3,507 | -3,178 | -1,648 | -3,974 | -4,542 |
| Other Income | 24 | -169 | 196 | 96 | 216 |
| Pre-tax Income | -3,483 | -3,347 | -1,452 | -3,878 | -4,326 |
| Net Income Continuous | -3,483 | -3,347 | -1,452 | -3,878 | -4,326 |
| Net Income | $-3,483 | $-3,347 | $-1,452 | $-3,878 | $-4,326 |
| EPS Basic Total Ops | -0.27 | -0.28 | -0.13 | -0.33 | -0.38 |
| EPS Basic Continuous Ops | -0.27 | -0.28 | -0.13 | -0.34 | -0.38 |
| EPS Diluted Total Ops | -0.27 | -0.28 | -0.13 | -0.33 | -0.38 |
| EPS Diluted Continuous Ops | -0.27 | -0.28 | -0.13 | -0.34 | -0.38 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.28 | -0.13 | -0.34 | -0.38 |
| EBITDA(a) | $-3,284 | $-2,949 | $-1,404 | $-3,732 | $-4,287 |